We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

MRCKα Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human MRCKalpha (1–473) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. Myotonic Dystrophy Kinase-Related Cdc42-Binding Kinase α (MRCKα) is a Cdc42/Rac/Rho interactive/binding serine/threonine kinase with multiple functional domains (1). MRCKs are effectors of RhoA and Cdc42, respectively, for actin reorganization. MRCKα is a critical regulator of signal transduction pathways in eukaryotic cells that are known principally for their role in regulating the cytoskeleton, and they do so by recruiting a variety of downstream ef...

Expand to Read More »

  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

MRCKα Kinase Enzyme System

Close Window

MRCKα Kinase Enzyme System

 Components

10μg
- V5710 $ 406.00 Add to cart

MRCKα Kinase Enzyme System

Close Window

MRCKα Kinase Enzyme System

 Components

1mg
- V6589 $ 5,990.00 Add to cart

ADP-Glo™ Kinase Assay + MRCKα Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + MRCKα Kinase Enzyme System

 Components

  • MRCKα Kinase Enzyme System

    V57101 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V5711 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V5710, V6589, V5711 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V5711 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V5711 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V5711 U.S. Pat. Nos. 7,741,067, 8,361,739, 8,603,767 and other patents and patents pending.

V5711 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V5711 U.S. Pat. No. 8,183,007 and other patents and patents pending.

V5711 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V5711 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.